Wedbush Initiates Coverage On Nuvalent with Outperform Rating, Announces Price Target of $39
Wedbush analyst David Nierengarten initiates coverage on Nuvalent (NASDAQ:NUVL) with a Outperform rating and announces Price Target of $39.
Reported Late Monday, Nuvalent Announces Pricing Of ~$230M Public Offering Of 6,865,672 Shares Of Class A Common Stock Common Stock At A Price Of $33.50/Share
Nuvalent, Inc. (NASDAQ:NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the pricing of its
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Gainers
Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Nasdaq Climbs 275 Points; S&P 500 Rises Over 2%
U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite surging more than 200 points on Friday.
Dow Jumps 600 Points; Crude Oil Down Over 1%
U.S. stocks extended gains midway through trading, with the Dow Jones surging more than 600 points on Friday.
Nuvalent To Present Preliminary Phase 1 Data From ARROS-1 Clinical Trial Of NVL-520 At 34th EORTC-NCI-AACR Symposium October 26-28 And Announces Pipeline Updates
CAMBRIDGE, Mass., Sept. 7, 2022 /PRNewswire/ -- Nuvalent, Inc. (NASDAQ:NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings (CCNB).
